John Boesel

Background

About John Boesel

As Chief Strategy & Investment Officer of FibroGenesis, John is focused on facilitating plans and strategies for its stakeholders toward the executing of its business model/exit strategy using FibroGenesis's disruptive fibroblast IP technology and its extensive patent portfolio. The ultimate goal of using this revolutionary cell therapy through the licensing, selling, development and partnering of the FibroGenesis IP therapeutic platform is to enable utilization and commercialization of these breakthroughs on a worldwide scale for the treatment and curing of humanity of many chronic diseases and illnesses. He is also President and Director of Global Energy Source Inc, a private investment holding company. A finance graduate from Arizona State University, he has over 35 years of experience within the securities industry and has assisted, consulted, or provided funding for numerous micro-cap, small-cap, and emerging market companies in a variety of industries and technologies worldwide, including the US, Europe and China. He is currently active in the corporate finance, consulting and advisory services through his company JB Diversified Financial and is involved in numerous and a diverse group of technology businesses and industry sectors. In addition John manages an investment fund partnership whose primary holding is FibroGenesis.